Portland Investment Counsel’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Portland Investment Counsel’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-20,000	Closed	-$133K	–	42
2023 Q3	$133K	Sell	20,000 -93,300	-82%	-$776K	0.06%	34
2023 Q2	$1.03M	Buy	113,300 +99,700	+733%	+$879K	0.51%	20
2023 Q1	$99K	Hold	13,600	–	–	0.05%	34
2022 Q4	$99K	Buy	+13,600	New	+$101K	0.06%	37

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Portland Investment Counsel's PNT Position: Q4 2023 in Review

Portland Investment Counsel sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 20,000 shares — an estimated $133K sold.

Portland Investment Counsel first reported a position in PNT in Q4 2022 and held it in 4 quarters. The position peaked at $1.03M in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Portland Investment Counsel reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Portland Investment Counsel sold 20,000 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $133K.
Portland Investment Counsel first reported a position in POINT Biopharma Global Inc. Common Stock in Q4 2022 and held it in 4 quarters.
Portland Investment Counsel's POINT Biopharma Global Inc. Common Stock position peaked at $1.03M in Q2 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Portland Investment Counsel's 13F filing for Q4 2023, filed 14 Feb 2024.